Clinical utility of a prediction tool to differentiate between breast cancer patients at high or low risk of chemotherapy-induced nausea and vomiting

ConclusionThe PRM was able to identify patients at greater risk of significant nausea but not the other CINV endpoints. As nausea remains a pertinent issue for patients with BC, the PRM could be used to identify these patients a priori for innovative treatment strategies.

http://link.springer.com/10.1007/s00520-021-06358-8

Source: Supportive Care in Cancer - October 26, 2021 Category: Cancer & Oncology Source Type: research